GATA2 Promotes Hematopoietic Development and Represses Cardiac Differentiation of Human Mesoderm.


Journal

Stem cell reports
ISSN: 2213-6711
Titre abrégé: Stem Cell Reports
Pays: United States
ID NLM: 101611300

Informations de publication

Date de publication:
10 09 2019
Historique:
received: 03 05 2018
revised: 12 07 2019
accepted: 15 07 2019
pubmed: 14 8 2019
medline: 19 6 2020
entrez: 13 8 2019
Statut: ppublish

Résumé

In vertebrates, GATA2 is a master regulator of hematopoiesis and is expressed throughout embryo development and in adult life. Although the essential role of GATA2 in mouse hematopoiesis is well established, its involvement during early human hematopoietic development is not clear. By combining time-controlled overexpression of GATA2 with genetic knockout experiments, we found that GATA2, at the mesoderm specification stage, promotes the generation of hemogenic endothelial progenitors and their further differentiation to hematopoietic progenitor cells, and negatively regulates cardiac differentiation. Surprisingly, genome-wide transcriptional and chromatin immunoprecipitation analysis showed that GATA2 bound to regulatory regions, and repressed the expression of cardiac development-related genes. Moreover, genes important for hematopoietic differentiation were upregulated by GATA2 in a mostly indirect manner. Collectively, our data reveal a hitherto unrecognized role of GATA2 as a repressor of cardiac fates, and highlight the importance of coordinating the specification and repression of alternative cell fates.

Identifiants

pubmed: 31402335
pii: S2213-6711(19)30261-9
doi: 10.1016/j.stemcr.2019.07.009
pmc: PMC6742600
pii:
doi:

Substances chimiques

GATA2 Transcription Factor 0
GATA2 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

515-529

Subventions

Organisme : Medical Research Council
ID : MC_PC_12009
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206328/Z/17/Z
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : T32 HL007899
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Nature. 1995 Feb 2;373(6513):432-4
pubmed: 7830794
Nat Commun. 2014 Jul 14;5:4372
pubmed: 25019369
Cardiovasc Res. 2017 Sep 1;113(11):1294-1306
pubmed: 28859300
Dev Biol. 2014 May 15;389(2):208-18
pubmed: 24583263
Cell Stem Cell. 2010 Oct 8;7(4):532-44
pubmed: 20887958
Blood. 2013 Jan 17;121(3):447-58
pubmed: 23169777
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Cell Stem Cell. 2015 Jun 4;16(6):712-24
pubmed: 26004780
J Biol Chem. 2000 Dec 15;275(50):38949-52
pubmed: 11042222
Stem Cell Reports. 2013 Jul 25;1(2):166-82
pubmed: 24052951
Stem Cells. 2017 Nov;35(11):2253-2266
pubmed: 28869683
Mol Cell Biol. 2010 Aug;30(15):3853-63
pubmed: 20516218
Crit Rev Oncol Hematol. 2012 Apr;82(1):1-17
pubmed: 21605981
J Exp Med. 2011 Nov 21;208(12):2417-27
pubmed: 22042975
Blood. 2014 Feb 6;123(6):809-21
pubmed: 24227816
Development. 2005 Mar;132(5):1117-26
pubmed: 15689374
J Exp Med. 2013 Dec 16;210(13):2843-50
pubmed: 24297996
Nat Genet. 2011 Sep 04;43(10):1012-7
pubmed: 21892162
Cell Stem Cell. 2008 May 8;2(5):497-507
pubmed: 18462699
Dev Cell. 2014 Dec 8;31(5):640-53
pubmed: 25490269
Cell Rep. 2018 Dec 4;25(10):2821-2835.e7
pubmed: 30517869
Cell. 2012 Aug 3;150(3):590-605
pubmed: 22863011
PLoS Genet. 2007 Aug;3(8):e140
pubmed: 17722983
Nature. 2019 Feb;566(7745):490-495
pubmed: 30787436
Bioinformatics. 2004 Dec 12;20(18):3710-5
pubmed: 15297299
J Clin Invest. 2012 Oct;122(10):3705-17
pubmed: 22996665
Stem Cell Reports. 2014 Mar 27;2(4):449-56
pubmed: 24749070
Cell Stem Cell. 2013 Oct 3;13(4):459-70
pubmed: 24094326
Nat Commun. 2018 Dec 18;9(1):5375
pubmed: 30560907
Stem Cell Reports. 2017 Jul 11;9(1):136-148
pubmed: 28648899
Blood. 2011 Sep 8;118(10):2656-8
pubmed: 21765025
Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13170-5
pubmed: 16141334
Exp Hematol. 2017 Jan;45:85-93.e2
pubmed: 27693385
Blood. 2016 Mar 17;127(11):1387-97; quiz 1518
pubmed: 26702063
EMBO J. 2015 Mar 12;34(6):759-77
pubmed: 25564442
J Clin Invest. 2012 Oct;122(10):3692-704
pubmed: 22996659
EMBO J. 2014 Jun 2;33(11):1212-26
pubmed: 24760698
Blood. 1999 Jan 15;93(2):488-99
pubmed: 9885210
Blood. 2014 Nov 13;124(20):3065-75
pubmed: 25185710
Nat Biotechnol. 2014 Jun;32(6):554-61
pubmed: 24837661
Blood. 2012 Apr 5;119(14):3295-305
pubmed: 22343916
Cell Stem Cell. 2013 May 2;12(5):587-601
pubmed: 23642367
Dev Cell. 2007 Aug;13(2):254-67
pubmed: 17681136
Blood. 1997 May 15;89(10):3636-43
pubmed: 9160668
J Exp Med. 2004 Oct 4;200(7):871-82
pubmed: 15466621
Development. 2011 Nov;138(21):4801-12
pubmed: 21989919
Nat Protoc. 2013 Jan;8(1):162-75
pubmed: 23257984
Cell. 2014 Nov 20;159(5):1070-1085
pubmed: 25416946
Nature. 1994 Sep 15;371(6494):221-6
pubmed: 8078582
Stem Cells. 2009 Mar;27(3):559-67
pubmed: 19259936
J Exp Med. 2013 Dec 16;210(13):2833-42
pubmed: 24297994
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Exp Hematol. 2008 Dec;36(12):1593-603
pubmed: 18809240
Nature. 2016 Jul 06;535(7611):289-293
pubmed: 27383781
Leukemia. 2015 Aug;29(8):1741-53
pubmed: 25778099
Dev Dyn. 2012 Sep;241(9):1454-64
pubmed: 22733530
Nucleic Acids Res. 2012 Jul;40(13):5819-31
pubmed: 22492510
Blood. 2015 Feb 12;125(7):1098-106
pubmed: 25540193
Blood. 2017 Apr 13;129(15):2092-2102
pubmed: 28179282
Blood. 1992 Aug 1;80(3):575-81
pubmed: 1638017
Mol Cell Biol. 1993 Jul;13(7):3999-4010
pubmed: 8321207
Dev Cell. 2016 Jan 11;36(1):9-23
pubmed: 26766440
Blood. 2009 Mar 19;113(12):2661-72
pubmed: 19168794
Nature. 2017 May 25;545(7655):432-438
pubmed: 28514439
Nat Immunol. 2008 Feb;9(2):129-36
pubmed: 18204427
Stem Cell Reports. 2018 Jul 10;11(1):197-211
pubmed: 29861167
Stem Cell Reports. 2019 Jul 9;13(1):31-47
pubmed: 31178416
Mol Cell. 2009 Nov 25;36(4):667-81
pubmed: 19941826

Auteurs

Julio Castaño (J)

Center of Regenerative Medicine in Barcelona (CMRB), Hospital Duran i Reynals, Gran Via de L'Hospitalet, 199-203, Hospitalet de Llobregat, Barcelona 08908, Spain; Center for Networked Biomedical Research on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), Madrid 28029, Spain.

Sergi Aranda (S)

Center for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Universitat Pompeu Fabra, Barcelona 08003, Spain.

Clara Bueno (C)

Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona 08036, Spain.

Fernando J Calero-Nieto (FJ)

Department of Hematology, Wellcome and MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.

Eva Mejia-Ramirez (E)

Center of Regenerative Medicine in Barcelona (CMRB), Hospital Duran i Reynals, Gran Via de L'Hospitalet, 199-203, Hospitalet de Llobregat, Barcelona 08908, Spain.

Jose Luis Mosquera (JL)

Bioinformatics Unit, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, 08908 Spain.

Enrique Blanco (E)

Center for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Universitat Pompeu Fabra, Barcelona 08003, Spain.

Xiaonan Wang (X)

Department of Hematology, Wellcome and MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.

Cristina Prieto (C)

Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona 08036, Spain.

Lorea Zabaleta (L)

Laboratory of Hematological Diseases, Fundación Inbiomed, San Sebastian, 20009, Spain.

Elisabetta Mereu (E)

CNAG-CRG, Center for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.

Meritxell Rovira (M)

Center of Regenerative Medicine in Barcelona (CMRB), Hospital Duran i Reynals, Gran Via de L'Hospitalet, 199-203, Hospitalet de Llobregat, Barcelona 08908, Spain.

Senda Jiménez-Delgado (S)

Center of Regenerative Medicine in Barcelona (CMRB), Hospital Duran i Reynals, Gran Via de L'Hospitalet, 199-203, Hospitalet de Llobregat, Barcelona 08908, Spain.

Daniel R Matson (DR)

Department of Cell and Regenerative Biology, UW-Madison Blood Research Program, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA.

Holger Heyn (H)

CNAG-CRG, Center for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain.

Emery H Bresnick (EH)

Department of Cell and Regenerative Biology, UW-Madison Blood Research Program, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA.

Berthold Göttgens (B)

Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona 08036, Spain.

Luciano Di Croce (L)

Center for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Universitat Pompeu Fabra, Barcelona 08003, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain.

Pablo Menendez (P)

Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona 08036, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain; Centro de Investigación Biomedica en Red en Cancer (CIBERONIC) ISCIII, Barcelona, Spain.

Angel Raya (A)

Center of Regenerative Medicine in Barcelona (CMRB), Hospital Duran i Reynals, Gran Via de L'Hospitalet, 199-203, Hospitalet de Llobregat, Barcelona 08908, Spain; Center for Networked Biomedical Research on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), Madrid 28029, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain.

Alessandra Giorgetti (A)

Center of Regenerative Medicine in Barcelona (CMRB), Hospital Duran i Reynals, Gran Via de L'Hospitalet, 199-203, Hospitalet de Llobregat, Barcelona 08908, Spain. Electronic address: agiorgetti@cmrb.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH